JP2019529443A5 - - Google Patents

Download PDF

Info

Publication number
JP2019529443A5
JP2019529443A5 JP2019515462A JP2019515462A JP2019529443A5 JP 2019529443 A5 JP2019529443 A5 JP 2019529443A5 JP 2019515462 A JP2019515462 A JP 2019515462A JP 2019515462 A JP2019515462 A JP 2019515462A JP 2019529443 A5 JP2019529443 A5 JP 2019529443A5
Authority
JP
Japan
Prior art keywords
sulfonyl
hydroxy
pyrrolidine
hydroxymethyl
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019515462A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019529443A (ja
JP7025414B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/055700 external-priority patent/WO2018055524A1/en
Publication of JP2019529443A publication Critical patent/JP2019529443A/ja
Publication of JP2019529443A5 publication Critical patent/JP2019529443A5/ja
Application granted granted Critical
Publication of JP7025414B2 publication Critical patent/JP7025414B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019515462A 2016-09-20 2017-09-20 Trpv4拮抗薬 Active JP7025414B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662396991P 2016-09-20 2016-09-20
US62/396,991 2016-09-20
US201762482296P 2017-04-06 2017-04-06
US62/482,296 2017-04-06
PCT/IB2017/055700 WO2018055524A1 (en) 2016-09-20 2017-09-20 Trpv4 antagonists

Publications (3)

Publication Number Publication Date
JP2019529443A JP2019529443A (ja) 2019-10-17
JP2019529443A5 true JP2019529443A5 (cg-RX-API-DMAC7.html) 2021-02-12
JP7025414B2 JP7025414B2 (ja) 2022-02-24

Family

ID=60084020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019515462A Active JP7025414B2 (ja) 2016-09-20 2017-09-20 Trpv4拮抗薬

Country Status (22)

Country Link
US (2) US10588891B2 (cg-RX-API-DMAC7.html)
EP (1) EP3515887B1 (cg-RX-API-DMAC7.html)
JP (1) JP7025414B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190047724A (cg-RX-API-DMAC7.html)
CN (1) CN109952289B (cg-RX-API-DMAC7.html)
AU (1) AU2017330618A1 (cg-RX-API-DMAC7.html)
CA (1) CA3036929A1 (cg-RX-API-DMAC7.html)
CY (1) CY1124682T1 (cg-RX-API-DMAC7.html)
DK (1) DK3515887T3 (cg-RX-API-DMAC7.html)
ES (1) ES2890986T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20211457T1 (cg-RX-API-DMAC7.html)
HU (1) HUE056059T2 (cg-RX-API-DMAC7.html)
LT (1) LT3515887T (cg-RX-API-DMAC7.html)
PL (1) PL3515887T3 (cg-RX-API-DMAC7.html)
PT (1) PT3515887T (cg-RX-API-DMAC7.html)
RS (1) RS62317B1 (cg-RX-API-DMAC7.html)
RU (1) RU2019111882A (cg-RX-API-DMAC7.html)
SI (1) SI3515887T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202100561T1 (cg-RX-API-DMAC7.html)
TW (1) TW201825458A (cg-RX-API-DMAC7.html)
UY (1) UY37410A (cg-RX-API-DMAC7.html)
WO (1) WO2018055524A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201825458A (zh) * 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產(第二)有限公司 Trpv4拮抗劑
EP3515889A1 (en) 2016-09-20 2019-07-31 GlaxoSmithKline Intellectual Property (No. 2) Limited Trpv4 antagonists
ES2877763T3 (es) 2016-09-20 2021-11-17 Glaxosmithkline Ip No 2 Ltd Antagonistas del trpv4
CN108836972A (zh) * 2018-08-16 2018-11-20 青岛大学 Ws6对trp通道的作用
KR20210129677A (ko) 2019-02-15 2021-10-28 노파르티스 아게 안구 표면 통증의 치료 방법
JP6994061B2 (ja) 2019-02-15 2022-01-14 ノバルティス アーゲー 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの製剤
CN115052478A (zh) * 2019-11-21 2022-09-13 犹他大学研究基金会 Trpv4受体配体
CA3180132A1 (en) 2020-04-30 2021-10-30 Raqualia Pharma Inc. Pyrimidin-4(3h)-one derivatives as trpv4 antagonists
WO2021233752A1 (en) 2020-05-19 2021-11-25 Bayer Aktiengesellschaft Trpa1 antagonists for the treatment of diseases associated with pain and inflammation
EP4178982A1 (en) 2020-07-13 2023-05-17 Precirix N.V. Antibody fragment against folr1
CA3189206A1 (en) 2020-07-16 2022-01-20 Raqualia Pharma Inc. Trpv4 inhibitor as therapeutic agent for ocular disease
CN112574090B (zh) * 2020-11-23 2022-04-29 浙大城市学院 一种含硫的多取代吡咯类化合物及其制备方法
WO2023203135A1 (en) 2022-04-22 2023-10-26 Precirix N.V. Improved radiolabelled antibody
JP2025517625A (ja) 2022-05-02 2025-06-10 プレシリックス・ナームローゼ・ベンノートシヤープ プレターゲティング

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
CY1492A (en) 1981-07-08 1990-02-16 Draco Ab Powder inhalator
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
AT396333B (de) 1982-10-08 1993-08-25 Glaxo Group Ltd Vorrichtung zur verabreichung von medikamenten an patienten, einrichtung mit mehreren solchen vorrichtungen und traeger mit medikamentbehaeltern hiefuer
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
GR861995B (en) 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
SK280968B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Balenie medikamentu na použite v inhalačnom prístroji
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
ES2201318T3 (es) 1996-08-28 2004-03-16 THE PROCTER & GAMBLE COMPANY Inhibidores de metaloproteasas de aminas ciclicas substituidas.
GB9700226D0 (en) 1997-01-08 1997-02-26 Glaxo Group Ltd Inhalation device
WO2003050154A2 (en) 2001-12-06 2003-06-19 Cornell Research Foundation, Inc. Catalytic carbonylation of three and four membered heterocycles
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
JP4969238B2 (ja) 2003-03-27 2012-07-04 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
DK1730676T3 (da) 2004-02-16 2013-11-04 Glaxo Group Ltd Tælleenhed til anvendelse med en medikamentfordeler
AR048523A1 (es) 2004-04-07 2006-05-03 Kalypsys Inc Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
AU2005237500A1 (en) 2004-04-28 2005-11-10 Merck Sharp & Dohme Corp. 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity
JP2007538106A (ja) 2004-05-20 2007-12-27 イーラン ファーマスーティカルズ、インコーポレイテッド γセクレターゼのN−環式スルホンアミド阻害剤
CN1329374C (zh) 2004-06-09 2007-08-01 上海靶点药物有限公司 作为ccr5拮抗剂的化合物
KR20070041742A (ko) 2004-07-12 2007-04-19 바이엘 크롭사이언스 아게 살진균제 및 살충제로서의 치환된 2-피롤리돈 유도체
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
AU2006331850A1 (en) 2005-12-21 2007-07-05 Schering Corporation Substituted aniline derivatives useful as histamine H3 antagonists
US20090012011A1 (en) 2006-01-11 2009-01-08 Smithkline Beecham Corporation Novel Compounds
JP2009542666A (ja) 2006-06-30 2009-12-03 シェーリング コーポレイション P53活性を増加させる置換ピペリジンおよびその使用
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
WO2009091941A1 (en) 2008-01-17 2009-07-23 Purdue Research Foundation Small molecule inhibitors of hiv proteases
DE102008008838A1 (de) * 2008-02-13 2009-08-20 Bayer Healthcare Ag Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung
CN102203074A (zh) 2008-06-20 2011-09-28 麦它波莱克斯股份有限公司 芳基gpr119激动剂及其用途
CN104918935B (zh) 2012-11-16 2017-07-28 百时美施贵宝公司 二氢吡唑gpr40调节剂
CN103896946B (zh) 2012-12-28 2018-04-03 浙江导明医药科技有限公司 用于预防及治疗多种自身免疫疾病的新化合物
MX364438B (es) 2013-03-15 2019-04-26 Araxes Pharma Llc Inhibidores covalentes de kras g12c.
EP2970215B1 (en) 2013-03-15 2019-04-17 AbbVie Deutschland GmbH & Co. KG Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
JP6272832B2 (ja) 2013-04-04 2018-01-31 武田薬品工業株式会社 複素環化合物
CN107001283B (zh) 2014-07-31 2021-05-25 国家健康与医学研究院 Flt3受体拮抗剂
TW201825458A (zh) * 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產(第二)有限公司 Trpv4拮抗劑
EP3515889A1 (en) 2016-09-20 2019-07-31 GlaxoSmithKline Intellectual Property (No. 2) Limited Trpv4 antagonists
ES2877763T3 (es) 2016-09-20 2021-11-17 Glaxosmithkline Ip No 2 Ltd Antagonistas del trpv4

Similar Documents

Publication Publication Date Title
JP2019529443A5 (cg-RX-API-DMAC7.html)
RU2019111882A (ru) Антагонисты trpv4
JP2019532052A5 (cg-RX-API-DMAC7.html)
US20240139194A1 (en) Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
JP2019532054A5 (cg-RX-API-DMAC7.html)
US12458642B2 (en) Metalloenzyme inhibitor compounds
US7999006B2 (en) Methods of using MEK inhibitors
RU2015139590A (ru) ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ
HRP20171913T1 (hr) Aminopirimidinilni spojevi kao inhibitori jak
JP2016526576A5 (cg-RX-API-DMAC7.html)
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
JP2015517566A5 (cg-RX-API-DMAC7.html)
JP2017535561A5 (cg-RX-API-DMAC7.html)
HRP20161011T1 (hr) Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2
CA2703125A1 (en) Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer
JP2017511794A5 (cg-RX-API-DMAC7.html)
JP2014500322A5 (cg-RX-API-DMAC7.html)
RU2009133846A (ru) Новые производные гидантоина в качестве ингибиторов металлопротеиназ
JP2023529701A (ja) アロステリックegfr阻害剤及びその使用方法
RU2019110821A (ru) Антагонисты trpv4
RU2007126746A (ru) Новые производные гидантоина в качестве ингибиторов металлопротеиназ
US20220009907A1 (en) Metalloenzyme inhibitor compounds
AU2024225909A1 (en) Covalent modifiers of akt1 and uses thereof
JP2008524211A5 (cg-RX-API-DMAC7.html)
CN114206342A (zh) 变构egfr抑制剂及其使用方法